Pain clinical trials in Utah
8 studies for Pain are looking for participants at sites in Utah.
Cities in Utah
An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin
- Adneuris Site 001101, Salt Lake City
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT07845071A Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 Years
- CenExel Salt Lake, Salt Lake City
RecruitingPhase 1Healthy volunteers welcome
Ages 6 to 11 · All sexes · Updated Jun 30, 2026 · NCT07632274Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
- VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
Recruiting
Ages 18 and older · All sexes · Updated May 4, 2026 · NCT04142177Prehospital Analgesia INtervention Trial (PAIN)
- University of Utah, Salt Lake City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Mar 9, 2026 · NCT05437575Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
- University of Utah Primary Care Clinics, Salt Lake City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Feb 3, 2026 · NCT06387290Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
- University of Utah, Salt Lake City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 30, 2025 · NCT06032559Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
- University of Utah, Salt Lake City
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Jun 5, 2025 · NCT07006675International Pachyonychia Congenita Research Registry
- Pachyonychia Congenita Project, Salt Lake City
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Nov 21, 2018 · NCT02321423From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.